Heuristic scoring method utilizing FDG-PET statistical parametric mapping in the evaluation of suspected Alzheimer

Jeremy N Ford1, Elizabeth M Sweeney2, Myrto Skafida3

  • 1Department of Radiology, Massachusetts General Hospital Boston, MA, United States.

Insights

A new heuristic scoring method using statistical parametric mapping (SPM) z-scores improves the detection of Alzheimer Disease (AD) and frontotemporal lobar degeneration (FTLD) on FDG-PET scans. This approach offers higher sensitivity than qualitative reads and matches machine learning performance.

Area of Science:

  • Neuroimaging
  • Nuclear Medicine
  • Neurology

Background:

  • Distinguishing frontotemporal lobar degeneration (FTLD) from Alzheimer Disease (AD) on FDG-PET can be challenging with qualitative review alone.
  • Statistical Parametric Mapping (SPM) shows promise in research but lacks clinical translation for dementia diagnosis.

Purpose of the Study:

  • To develop a heuristic scoring method using SPM z-scores for dementia diagnosis.
  • To compare this non-ML scoring method against initial qualitative reads and machine learning (ML) benchmarks.

Main Methods:

  • 65 patients with suspected dementia underwent FDG-PET/CT or PET/MRI.
  • SPM software generated z-scores using whole brain (W) or cerebellar (C) normalization.
  • A non-ML heuristic scoring system was applied using region counts below a z-score cutoff; random forest models were built using W, C, or WC z-scores.

Main Results:

  • The non-ML scoring system and random forest models showed significantly higher sensitivity for detecting AD compared to initial qualitative reads (0.89-1.00 vs. 0.22).
  • A categorical random forest model distinguishing AD, FTLD, and normal cases had accuracy comparable to the non-ML scoring model (0.63 vs. 0.61).

Conclusions:

  • The non-ML heuristic scoring system using SPM z-scores approximates ML-based diagnostic performance.
  • This novel approach demonstrates improved sensitivity for AD detection over qualitative reads and may enhance clinical diagnostic performance.